drugset

drugset / Trial / NCT03623282

Study Regarding the Clinical Efficacy of Synatura® in Patients With Chronic Bronchitis Type COPD

NCT03623282 ↗

Phase 4 Completed 30 enrolled Ahn-Gook Pharmaceuticals Co.,Ltd

NaSingle-groupOpen-labelTreatment

Summary

This study aims to examine the clinical efficacy of synatura in patients with chronic bronchitis type COPD in Korea.

Timeline

Start: 2017-04-17
Primary completion: 2018-05-02
Completion: 2018-05-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Synatura®	Unknown	15 ml	—

Indications